Ontology highlight
ABSTRACT:
INSTRUMENT(S): Q Exactive Plus
ORGANISM(S): Escherichia Coli Trypanosoma Brucei
DISEASE(S): Trypanosomiasis
SUBMITTER: Rosario Durán
LAB HEAD: Rosario Durán
PROVIDER: PXD027729 | Pride | 2022-04-04
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
200710_Ecoli_strainB_BL21-DE3_4156sequences_TbTryS_T_brucei.fasta | Fasta | |||
200922_Control_2.raw | Raw | |||
200922_EbSe_1.raw | Raw | |||
200922_EbSe_2.raw | Raw | |||
200922_control_1.raw | Raw |
Items per page: 5 1 - 5 of 10 |
Benítez Diego D Franco Jaime J Sardi Florencia F Leyva Alejandro A Durán Rosario R Choi Gahee G Yang Gyongseon G Kim Taehee T Kim Namyoul N Heo Jinyeong J Kim Kideok K Lee Honggun H Choi Inhee I Radu Constantin C Shum David D No Joo Hwan JH Comini Marcelo A MA
Journal of enzyme inhibition and medicinal chemistry 20221201 1
Trypanothione synthetase (TryS) catalyses the synthesis of <i>N</i><sup>1</sup><i>,N<sup>8</sup></i>-bis(glutathionyl)spermidine (trypanothione), which is the main low molecular mass thiol supporting several redox functions in trypanosomatids. TryS attracts attention as molecular target for drug development against pathogens causing severe and fatal diseases in mammals. A drug discovery campaign aimed to identify and characterise new inhibitors of TryS with promising biological activity was cond ...[more]